Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03562767 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes
A NA study, sponsored by Emory University.
- Terminated
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03562767 is a NA study that was terminated before completion, run by Emory University. The registered enrollment target is 20 participants.
The verdict
NCT03562767, a NA study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The main purpose of the study is to assess the feasibility and acceptability of a Culturally-Tailored Cognitive Behavior intervention (CT-CB) for African American patients with uncontrolled Type 2 diabetes. After the baseline visit subjects will be randomly assigned to undergo a six session group-based or web-based behavioral intervention (CT-CB) program or to general education (usual care). The intervention duration is 12 weeks.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Group-based Cognitive Behavioral Intervention
- BEHAVIORAL Web-based Cognitive Behavioral Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2019-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03562767
The ClinicalTrials.gov registry entry for NCT03562767 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT03562767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03562767 about?
NCT03562767 is a clinical study titled "Cognitive Behavioral Therapy for African Americans With Uncontrolled Type-2 Diabetes". The main purpose of the study is to assess the feasibility and acceptability of a Culturally-Tailored Cognitive Behavior intervention (CT-CB) for African American patients with uncontrolled Type 2 diabetes. After the baseline visit subjects will be randomly assigned to undergo a six session group-ba...
What is the current status of trial NCT03562767?
This trial is currently terminated. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-05. Estimated completion is 2019-05-30.
What interventions are being tested in trial NCT03562767?
The interventions under investigation include: Usual Care (BEHAVIORAL), Group-based Cognitive Behavioral Intervention (BEHAVIORAL), Web-based Cognitive Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03562767?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.